Where Science Meets Leadership, Healthcare Thrives
CEO,
Enovis
In the rapidly evolving landscape of healthcare technology in the United States, challenges such as integrating advanced medical solutions, enhancing patient outcomes, and improving operational efficiency have become paramount. Leading the charge to address these issues is Matt Trerotola, CEO of Enovis, a company dedicated to developing clinically di erentiated solutions that restore motion and improve lives. Under his leadership, Enovis has emerged as a beacon of innovation, partnering with healthcare professionals to create smarter, personalized, and more effective care solutions.
Matt Trerotola’s professional journey began with a solid foundation in chemical engineering, earning his Bachelor of Science from the University of Virginia in 1989. He further honed his business acumen by obtaining an MBA from Harvard Business School in 1995. These academic achievements set the stage for a diverse and impactful career.
In 2015, Matt took the helm as CEO of Colfax Corporation, which later transformed into Enovis, marking a pivotal shift towards medical technology. Under his leadership, Enovis has focused on developing innovative solutions that enhance patient outcomes and streamline healthcare workflows. The company’s extensive range of products, services, and integrated technologies, including marketleading brands like DonJoyĀ®, AircastĀ®, and EMPOWRĀ®, reflects this commitment. Matt emphasizes the importance of continuous improvement and collaboration in driving innovation. “Our purpose is creating better together,” he states. “When we talk about creating better together, it means better solutions for our surgeons, which means better outcomes for their patients. It also means better career paths for our associates and better relationships in our communities.”
Matt’s leadership has not gone unnoticed. He was named a Top 50 Healthcare Technology CEO by the Healthcare Technology Report, an accolade that underscores his contributions to advancing medical technology and improving patient outcomes. This recognition reflects his dedication to fostering a culture of innovation and excellence within Enovis.
Under Matt’s guidance, Enovis is poised for significant growth. The company is approaching the milestone of becoming a $2 billion enterprise, with a clear strategy for continued expansion. This plan focuses on creating a highgrowth medical technology company that extends beyond orthopedics to help more patients lead active lifestyles. Matt’s vision for Enovis is clear: to be one of the great growth stories in the history of the MedTech industryā€”a company with high integrity and exceptional performance. His leadership continues to drive Enovis towards this goal, ensuring that the company remains at the forefront of medical innovation.
Matt Trerotola’s journey from chemical engineering to leading a global medical technology company exemplifies a career dedicated to innovation, strategic growth, and improving patient care. Through his leadership, Enovis has navigated the challenges of the healthcare industry, emerging as a leader in developing solutions that enhance patient outcomes and transform healthcare delivery. As the company looks to the future, Matt’s vision and commitment to continuous improvement will undoubtedly continue to guide Enovis towards new heights in medical technology
Matt’s early career was marked by significant roles at industry-leading organizations. He spent a considerable part of his career at DuPont, where he held various leadership positions, including Executive Vice President. In this capacity, he was responsible for substantial revenue streams in safety, protection, and electronic materials, and oversaw corporate operations in the Asia-Pacific region. His tenure at DuPont was instrumental in shaping his strategic vision and understanding of global markets. Following his time at DuPont, Matt joined Danaher Corporation, serving as Vice President and Group Executive for the Life Sciences platform. Here, he oversaw a portfolio of companies, driving growth through innovation and strategic acquisitions. His leadership at Danaher further solidified his reputation as a dynamic and forwardthinking executive
Recognizing the complexities of modern healthcare, Matt has steered Enovis towards solutions that not only meet clinical needs but also enhance operational efficiency for surgeons and clinicians worldwide. By fostering partnerships with healthcare professionals and investing in strategic acquisitions, Enovis has expanded its capabilities and market reach. A notable example of this strategy is the acquisition of LimaCorporate, a move that bolsters Enovis’s position in the global orthopedics market. This acquisition aligns with Matt’s vision of providing comprehensive, integrated solutions that improve patient care.
At the core of Matt’s leadership philosophy is a commitment to continuous improvement. He believes in empowering teams to seek better ways of doing things, a principle that has become a cornerstone of Enovis’s corporate culture. “Continuous improvement is our core value, and that means we are never satisfied,” he explains. “With the great opportunities for growth in orthopedics and beyond, this intensity is typically focused on how we accelerate our growth path.”
CEO Outlook Global is a monthly business magazine featuring original insights and exclusive features on entrepreneurs, business owners, CEOs, C-suite executives, and innovators shaping industries worldwide.
Never miss any important news. Subscribe to our newsletter.
Copyright 2025 CEO Outlook Global. All rights reserved.
